Effects of Rett Syndrome Mutations of the Methyl-CpG Binding Domain of the Transcriptional Repressor MeCP2 on Selectivity for Association with Methylated DNA
- 26 May 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 39 (24), 7100-7106
- https://doi.org/10.1021/bi0001271
Abstract
We have investigated the properties of mutant forms of the methyl-CpG binding transcriptional repressor MeCP2 associated with Rett syndrome, a childhood neurodevelopmental disorder. We find that four Rett syndrome mutations at known sites within the methyl-CpG binding domain (MBD) impair binding to methylated DNA, but have little effect on nonspecific interactions with unmethylated DNA. Three of these mutations (R106W, R133C, and F155S) have their binding affinities for methylated DNA reduced more than 100-fold; this is consistent with the hypothesis that impaired selectivity for methylated DNA of mutant MeCP2 contributes to Rett syndrome. However, a fourth mutant, T158M, has its binding affinity for methylated DNA reduced only 2-fold, indicative either of additional distinct regulatory functions associated with the MBD or of an exquisite sensitivity of developing neurons to the selective association of MeCP2 with methylated DNA.Keywords
This publication has 4 references indexed in Scilit:
- Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1The EMBO Journal, 1999
- The solution structure of the domain from MeCP2 that binds to methylated DNAJournal of Molecular Biology, 1999
- CpG methylation, chromatin structure and gene silencing---a three-way connectionThe EMBO Journal, 1998
- Rett's Syndrome: Prevalence and Impact on Progressive Severe Mental Retardation in GirlsActa Paediatrica, 1985